Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001209191-21-011888

President and CEO sold 19,402 shares at an average $12.79 ($248,148)

  • President and CEO acquired 43,028 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KANE MATTHEW R. · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-16 Exercise or conversion : show line 1 in the form +21,514 $0.04 $861 1,875,525 D
2021-02-16 Sale : show line 2 in the form −9,697 $13.30 $128,970 1,865,828 D
2021-02-17 Exercise or conversion : show line 3 in the form +21,514 $0.04 $861 1,887,342 D
2021-02-17 Sale : show line 4 in the form −9,705 $12.28 $119,177 1,877,637 D
Open-market sales · 19,402 sh · avg $12.79 · $248,148

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-16 Exercise or conversion : show line 5 in the form Employee Stock Option (Right to Buy) −21,514 $0.04 2021-05-17 21,514 236,654 D
2021-02-17 Exercise or conversion : show line 6 in the form Employee Stock Option (Right to Buy) −21,514 $0.04 2021-05-17 21,514 215,140 D
Loading xslF345X03/doc4.xml…